Literature DB >> 22338074

Parathyroid hormone induces bone formation in phosphorylation-deficient PTHR1 knockin mice.

Nabanita S Datta1, Tareq A Samra, Abdul B Abou-Samra.   

Abstract

Activation of G protein-coupled receptors by agonists leads to receptor phosphorylation, internalization of ligand receptor complexes, and desensitization of hormonal response. The role of parathyroid hormone (PTH) receptor 1, PTHR1, is well characterized and known to regulate cellular responsiveness in vitro. However, the role of PTHR1 phosphorylation in bone formation is yet to be investigated. We have previously demonstrated that impaired internalization and sustained cAMP stimulation of phosphorylation-deficient (PD) PTHR1 leads to exaggerated cAMP response to subcutaneous PTH infusion in a PD knockin mouse model. To understand the physiological role of receptor internalization on PTH bone anabolic action, we examined bone parameters of wild-type (WT) and PD knockin female and male mice following PTH treatment. We found a decrease in total and diaphyseal bone mineral density in female but not in male PD mice compared with WT controls at 3-6 mo of age. This effect was attenuated at older age groups. PTH administration displayed increased bone volume and trabecular thickness in the vertebrae and distal femora of both WT and PD animals. These results suggest that PTHR1 phosphorylation does not play a major role in the anabolic action of PTH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22338074      PMCID: PMC3361988          DOI: 10.1152/ajpendo.00380.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  22 in total

1.  Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling.

Authors:  Hesham A W Tawfeek; Fang Qian; Abdul B Abou-Samra
Journal:  Mol Endocrinol       Date:  2002-01

Review 2.  G-protein-coupled receptors: regulatory role of receptor kinases and arrestin proteins.

Authors:  R J Lefkowitz; J Inglese; W J Koch; J Pitcher; H Attramadal; M G Caron
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1992

3.  Beta-arrestin-biased parathyroid hormone ligands: a new approach to the development of agents that stimulate bone formation.

Authors:  Serge L Ferrari; Mary L Bouxsein
Journal:  Sci Transl Med       Date:  2009-10-07       Impact factor: 17.956

4.  Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis.

Authors:  Guillermo Romero; W Bruce Sneddon; Yanmei Yang; David Wheeler; Harry C Blair; Peter A Friedman
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

5.  Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.

Authors:  Akiko Iida-Klein; Hua Zhou; Shi Shou Lu; Lance R Levine; Mercedes Ducayen-Knowles; David W Dempster; Jeri Nieves; Robert Lindsay
Journal:  J Bone Miner Res       Date:  2002-05       Impact factor: 6.741

6.  Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts.

Authors:  M E Marsh; A M Munne; J J Vogel; Y Cui; R T Franceschi
Journal:  J Bone Miner Res       Date:  1995-11       Impact factor: 6.741

7.  PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.

Authors:  Nabanita S Datta; Chen Chen; Janice E Berry; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2005-01-18       Impact factor: 6.741

8.  Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy.

Authors:  S L Ferrari; V Behar; M Chorev; M Rosenblatt; A Bisello
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

9.  Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.

Authors:  Sébastien Ferrandon; Timothy N Feinstein; Marian Castro; Bin Wang; Richard Bouley; John T Potts; Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Nat Chem Biol       Date:  2009-08-23       Impact factor: 15.040

10.  Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50).

Authors:  W Bruce Sneddon; Colin A Syme; Alessandro Bisello; Clara E Magyar; Moulay Driss Rochdi; Jean-Luc Parent; Edward J Weinman; Abdul B Abou-Samra; Peter A Friedman
Journal:  J Biol Chem       Date:  2003-08-14       Impact factor: 5.157

View more
  5 in total

1.  Guidelines for Dual Energy X-Ray Absorptiometry Analysis of Trabecular Bone-Rich Regions in Mice: Improved Precision, Accuracy, and Sensitivity for Assessing Longitudinal Bone Changes.

Authors:  Jiayu Shi; Soonchul Lee; Michael Uyeda; Justine Tanjaya; Jong Kil Kim; Hsin Chuan Pan; Patricia Reese; Louis Stodieck; Andy Lin; Kang Ting; Jin Hee Kwak; Chia Soo
Journal:  Tissue Eng Part C Methods       Date:  2016-04-15       Impact factor: 3.056

Review 2.  Serotonin and serotonin transport in the regulation of lactation.

Authors:  Aaron M Marshall; Laura L Hernandez; Nelson D Horseman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-18       Impact factor: 2.673

3.  MKP1-dependent PTH modulation of bone matrix mineralization in female mice is osteoblast maturation stage specific and involves P-ERK and P-p38 MAPKs.

Authors:  Chandrika D Mahalingam; Bharat Reddy Sampathi; Sonali Sharma; Tanuka Datta; Varsha Das; Abdul B Abou-Samra; Nabanita S Datta
Journal:  J Endocrinol       Date:  2013-02-25       Impact factor: 4.286

4.  Small molecule inhibition of the Na(+)/H(+) exchange regulatory factor 1 and parathyroid hormone 1 receptor interaction.

Authors:  Jeremy M Fitzpatrick; Maria Pellegrini; Patrick R Cushing; Dale F Mierke
Journal:  Biochemistry       Date:  2014-09-15       Impact factor: 3.162

5.  Anabolic actions of PTH in murine models: two decades of insights.

Authors:  Laura E Zweifler; Amy J Koh; Stephanie Daignault-Newton; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2021-07-27       Impact factor: 6.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.